| |
| Issue |
Title |
| |
| Vol 18, No 1 (2023) |
Comparative clinical and economic evaluation of polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone (R-CHP) in the 1st line therapy for adult patients with diffuse large B-cell lymphoma |
Abstract
PDF (Rus)
|
|
I. N. Dyakov |
| |
| No 4 (2009) |
Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: results of «Novartis research» |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| No 2 (2009) |
Immediate side effects study of locally manufactured filgrastim («Leucostim®») in neutropenia treatment and prophylactics in children |
Abstract
PDF (Rus)
|
|
N. Yu. Shipovskaya, E. V. Samochatova, O. B. Polushkina, M. A. Maschan, I. I. Kalinina, A. N. Gracianskay, M. N. Kostileva, A. A. Maschan |
| |
| No 3 (2010) |
Bendamustine: a new view on treatment of chronic lymphocytic leukemia |
Abstract
PDF (Rus)
|
|
Ye. A. Nikitin |
| |
| No 3 (2010) |
Osteodestruction markers and quality of life parameters at pomegara (pamidronate) treatment in multiple myeloma patients with lytic bone lesions |
Abstract
PDF (Rus)
|
|
V. V. Lunin, Ye. V. Yurova, O. A. Kudryavtseva, S. V. Minenko, V. V. Ptushkin |
| |
| No 4 (2008) |
Clinical efficacy of dacogen in myelodysplastic syndrome |
Abstract
PDF (Rus)
|
|
A. K. Golenkov, G. A. Dudina, I. V. Buravtsova, E. V. Kataeva, N. V. Oparina |
| |
| No 1 (2009) |
Stimulation of platelet production: the new treatment approach to chronic immune thrombocytopenic purpura |
Abstract
PDF (Rus)
|
|
A. A. Maschan, A. G. Rumyantsev |
| |
| Vol 17, No 4 (2022) |
Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity |
Abstract
PDF (Rus)
|
|
A. R. Kasimova, A. S. Kolbin, M. A. Proskurin, Yu. E. Balykina |
| |
| Vol 17, No 3 (2022) |
Comparative clinical and economic assessment of polatuzumab vedotin therapy in combination with bendamustine and rituximab for adult transplantation-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma |
Abstract
PDF (Rus)
|
|
I. N. Dyakov, K. K. Bushkova |
| |
| Vol 15, No 4 (2020) |
Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma |
Abstract
PDF (Rus)
|
|
N. A. Avxentyev, E. M. Pazuhina, G. S. Tumyan, P. A. Zeynalova |
| |
| Vol 15, No 1 (2020) |
Pharmacoeconomic aspects of recurrent / refractory chronic lymphocytic leukemia treatment |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, E. A. Stadnik |
| |
| Vol 14, No 4 (2019) |
Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers |
Abstract
PDF (Rus)
|
|
S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borоzinets, A. A. Kazarov, М. S. Pantyushenko |
| |
| Vol 11, No 3 (2016) |
Proteasome inhibitors: situation and prospects (literature review and own data) |
Abstract
PDF (Rus)
|
|
A. A. Rukavitsyn, O. A. Rukavitsyn |
| |
| Vol 9, No 3 (2014) |
Role of biosimilars in neutropenia prevention in cancer patients |
Abstract
|
|
V. V. Ptushkin |
| |
| Vol 9, No 3 (2014) |
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy |
Abstract
PDF (Rus)
|
|
D. J. Kuter, J. B. Bussel, A. Newland, R. I. Baker, R. M. Lyons, J. Wasser, J.-F. Viallard, G. Macik, M. Rummel, K. Nie, S. Jun |
| |
| Vol 9, No 2 (2014) |
Colistine pharmacokinetics and Colistimethate sodium daily dose calculation in children with chemotherapy induced neutropenia |
Abstract
PDF (Rus)
|
|
V. I. Zakharevich, V. V. Dmitriev |
| |
| Vol 6, No 1 (2011) |
Treatment of patients with refractory immune thrombocytopenia: literature review and case report |
Abstract
PDF (Rus)
|
|
V. V. Ptushkin, S. V. Minenko, E. R. Biyachuev, A. V. Pshonkin, A. V. Shubina |
| |
| Vol 8, No 2 (2013) |
Influence of low molecular weight heparin on cancer patients’ survival |
Abstract
PDF (Rus)
|
|
V. V. Ptushkin |
| |
| Vol 8, No 2 (2013) |
Anemia in cancer patients: current treatment options (review) |
Abstract
PDF (Rus)
|
|
V. M. Chernov, V. V. Ptushkin |
| |
| Vol 8, No 1 (2013) |
Modern concepts of biosimilars in hematology and oncology |
Abstract
PDF (Rus)
|
|
V. V. Ptushkin |
| |
| Vol 8, No 2 (2013) |
Adverse events of modern antifungal drugs during treatment of invasive fungal infections |
Abstract
PDF (Rus)
|
|
N. V. Dmitrieva, I. N. Petukhova |
| |
| Vol 8, No 2 (2013) |
Immune thrombocytopenia: clinical manifestation and therapy response. The interim analysis of Russian register of patients with primary immune thrombocytopenia and literature review |
Abstract
PDF (Rus)
|
|
I. A. Lisukov, A. A. Maschan, A. V. Shamardina, T. V. Chagorova, I. L. Davydkin, T. M. Sycheva, T. P. Zagoskina, E. V. Karyagina, G. N. Salogub, M. T. Savinova, T. V. Shelekhova, L. G. Kovaleva, T. V. Shneyder, A. N. Unzhekova, E. E. Kuznetsova, Yu. V. Shatokhin, M. O. Ivanova, E. Yu. Vinogradova, E. M. Volodicheva, I. V. Markova, O. V. Kanyukova, K. M. Abdulkadyrov, Yu. A. Sedlova, S. M. Osyunikhina, K. D. Kaplanov, N. V. Tsvetaeva, A. R. Akhmadeev, O. S. Uspenskaya, A. D. Kulagin, N. V. Medvedeva, A. G. Rumyantsev, B. V. Afanasiev |
| |
| Vol 9, No 1 (2014) |
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review |
Abstract
PDF (Rus)
|
|
N. V. Dmitrieva, I. N. Petukhova |
| |
| Vol 9, No 1 (2014) |
Clinical experience with romiplostim |
Abstract
PDF (Rus)
|
|
G. B. Kuchma, L. K. Kozlova, Ye. Ye. Kuznetsova, S. B. Borisyuk |
| |
| Vol 8, No 3 (2013) |
Clinical and biochemical features of some intravenous iron complexes |
Abstract
PDF (Rus)
|
|
S. Yu. Abashin, E. N. Misyurina, E. I. Zhelnova, A. V. Misyurin |
| |
| 1 - 25 of 25 Items |
|
